Yeah. If Alz completely bombs, along with PDD and Rett and no trials start and we find out sigma 1 is a fantasy and all our IP is written on toilet paper.
If Alz fails miserably with zero promise, then I could see valuation cut in half. We have never had any Alz potential in our valuation anyway.